Adverum Biotechnologies, Inc.

Works in Cardiovascular · Genetic & rare · GI & liver · Metabolic & endocrine · Neurology · Respiratory

Adverum Biotechnologies, Inc. is a clinical trial sponsor. It has 6 active clinical trials with 974 planned participants, across 6 therapeutic areas. Since 2021 it has completed 4 trials and stopped 0 early.

Trial track record · since 2021

6Active trials974 planned participants
4Completed3 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 6 active trials

StageTrialStatus

Questions about Adverum Biotechnologies, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-27.

Approve Suite is not affiliated with Adverum Biotechnologies, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.